Symbols / RGNT $9.40 +526.67% Regentis Biomaterials Ltd.
RGNT Chart
Stock Fundamentals
|
|
|
|
|
|
About
Official websiteRegentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is based in Herzliya, Israel.
Ratings
Current target
$9.40
Low
$10.00
High
$10.00
Mean
$10.00
- RGNT Stock Erupts As GelrinC European Rollout Plans Ignite Trading - StocksToTrade Mon, 15 Jun 2026 14
- Why Did RGNT Stock Surge More Than 850% Today? - Stocktwits Mon, 15 Jun 2026 18
- [RW] REGENTIS BIOMATERIALS LTD. SEC Filing - Stock Titan Mon, 15 Jun 2026 15
- These stocks are moving in today's after hours session - ChartMill Mon, 15 Jun 2026 21
- Regentis Biomaterials Jumps After Firm Scraps Public Offer - TechStock² Mon, 15 Jun 2026 19
- RGNT Stock Slides After Volatile Spike Draws Trader Focus - timothysykes.com ue, 09 Jun 2026 13
- Discover the most active stocks in Monday's session. - ChartMill Mon, 15 Jun 2026 18
- $Regentis Biomaterials (RGNT.US)$ Exited at 5.2 - Moomoo ue, 09 Jun 2026 14
- RGNT Stock Rockets On High-Volume Breakout Volatility - StocksToTrade ue, 09 Jun 2026 14
- symbol__ Stock Quote Price and Forecast - CNN Sat, 06 Sep 2025 17
- Regentis Biomaterials (RGNT) Is 'One to Watch' - Yahoo Finance hu, 28 May 2026 07
- RGNT Stock Price and Chart — AMEX:RGNT - TradingView hu, 20 Nov 2025 17
- Regentis Biomaterials (NASDAQ: RGNT) 2026 AGM covers director pay and options - Stock Titan hu, 04 Jun 2026 07
- Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell - TechStock² ue, 09 Jun 2026 13
- Wednesday's session: gap up and gap down stocks - ChartMill Wed, 10 Jun 2026 14
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
8.62
+1024.79%
|
-0.93
-148.27%
|
1.93
+37.24%
|
1.41
|
| Research And Development |
|
0.33
+120.13%
|
-1.64
-303.97%
|
0.81
-16.99%
|
0.97
|
| Selling General And Administration |
|
8.29
+1064.04%
|
0.71
-36.71%
|
1.12
+158.03%
|
0.44
|
| General And Administrative Expense |
|
8.29
+1064.04%
|
0.71
-36.71%
|
1.12
+158.03%
|
0.44
|
| Salaries And Wages |
|
7.55
|
0.00
|
0.00
|
—
|
| Other Gand A |
|
0.67
+3.73%
|
0.64
-39.28%
|
1.06
+200.85%
|
0.35
|
| Total Expenses |
|
8.62
+1024.79%
|
-0.93
-148.27%
|
1.93
+37.24%
|
1.41
|
| Operating Income |
|
-8.62
-1024.79%
|
0.93
+148.27%
|
-1.93
-37.24%
|
-1.41
|
| Total Operating Income As Reported |
|
-6.97
-847.64%
|
0.93
+148.27%
|
-1.93
-37.24%
|
-1.41
|
| EBITDA |
|
-13.32
-367.98%
|
4.97
+225.59%
|
-3.96
-173.22%
|
-1.45
|
| Normalized EBITDA |
|
-13.55
-407.16%
|
4.41
+211.64%
|
-3.95
-118.88%
|
-1.81
|
| EBIT |
|
-13.32
-367.98%
|
4.97
+225.59%
|
-3.96
-173.22%
|
-1.45
|
| Total Unusual Items |
|
0.23
-58.68%
|
0.56
+9416.67%
|
-0.01
-101.68%
|
0.36
|
| Total Unusual Items Excluding Goodwill |
|
0.23
-58.68%
|
0.56
+9416.67%
|
-0.01
-101.68%
|
0.36
|
| Net Income |
|
-13.65
-384.27%
|
4.80
+216.19%
|
-4.13
-185.16%
|
-1.45
|
| Pretax Income |
|
-13.65
-384.27%
|
4.80
+216.19%
|
-4.13
-185.16%
|
-1.45
|
| Net Non Operating Interest Income Expense |
|
-5.26
-258.91%
|
3.31
+250.80%
|
-2.19
-450.13%
|
-0.40
|
| Interest Expense Non Operating |
|
0.32
+89.47%
|
0.17
-1.16%
|
0.17
|
0.00
|
| Net Interest Income |
|
-5.26
-258.91%
|
3.31
+250.80%
|
-2.19
-450.13%
|
-0.40
|
| Interest Expense |
|
0.32
+89.47%
|
0.17
-1.16%
|
0.17
|
0.00
|
| Other Income Expense |
|
0.23
-58.68%
|
0.56
+9416.67%
|
-0.01
-101.68%
|
0.36
|
| Other Non Operating Income Expenses |
|
—
|
3.48
+272.51%
|
-2.02
-408.56%
|
-0.40
|
| Gain On Sale Of Security |
|
0.23
-58.68%
|
0.56
+9416.67%
|
-0.01
-101.68%
|
0.36
|
| Tax Rate For Calcs |
|
0.00
-100.00%
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
-100.00%
|
0.13
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-13.65
-384.27%
|
4.80
+216.19%
|
-4.13
-185.16%
|
-1.45
|
| Net Income From Continuing Operation Net Minority Interest |
|
-13.65
-384.27%
|
4.80
+216.19%
|
-4.13
-185.16%
|
-1.45
|
| Net Income From Continuing And Discontinued Operation |
|
-13.65
-384.27%
|
4.80
+216.19%
|
-4.13
-185.16%
|
-1.45
|
| Net Income Continuous Operations |
|
-13.65
-384.27%
|
4.80
+216.19%
|
-4.13
-185.16%
|
-1.45
|
| Normalized Income |
|
-13.88
-417.56%
|
4.37
+205.93%
|
-4.13
-128.46%
|
-1.81
|
| Net Income Common Stockholders |
|
-13.69
-388.07%
|
4.75
+213.71%
|
-4.18
-179.23%
|
-1.50
|
| Otherunder Preferred Stock Dividend |
|
0.04
-8.33%
|
0.05
+0.00%
|
0.05
+0.00%
|
0.05
|
| Diluted EPS |
|
—
|
0.92
+213.71%
|
-0.81
-179.23%
|
-0.29
|
| Basic EPS |
|
—
|
0.92
+213.71%
|
-0.81
-179.23%
|
-0.29
|
| Basic Average Shares |
|
—
|
5.18
+0.00%
|
5.18
+0.00%
|
5.18
|
| Diluted Average Shares |
|
—
|
5.18
+0.00%
|
5.18
+0.00%
|
5.18
|
| Diluted NI Availto Com Stockholders |
|
-13.69
-388.07%
|
4.75
+213.71%
|
-4.18
-179.23%
|
-1.50
|
| Rent And Landing Fees |
|
0.07
-2.90%
|
0.07
+4.55%
|
0.07
-21.43%
|
0.08
|
| Rent Expense Supplemental |
|
0.07
-2.90%
|
0.07
+4.55%
|
0.07
-21.43%
|
0.08
|
| Total Other Finance Cost |
|
4.94
+241.80%
|
-3.48
-272.16%
|
2.02
+406.77%
|
0.40
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
7.62
+1480.50%
|
0.48
+33.89%
|
0.36
-79.03%
|
1.72
|
| Current Assets |
|
7.62
+1480.50%
|
0.48
+33.89%
|
0.36
-79.03%
|
1.72
|
| Cash Cash Equivalents And Short Term Investments |
|
7.38
+3121.83%
|
0.23
-33.62%
|
0.34
-72.18%
|
1.24
|
| Cash And Cash Equivalents |
|
7.38
+3121.83%
|
0.23
-33.62%
|
0.34
-72.18%
|
1.24
|
| Receivables |
|
0.23
+215.07%
|
0.07
+812.50%
|
0.01
-69.23%
|
0.03
|
| Other Receivables |
|
0.23
+215.07%
|
0.07
+812.50%
|
0.01
-69.23%
|
0.03
|
| Prepaid Assets |
|
0.01
-94.44%
|
0.18
+2471.43%
|
0.01
-98.45%
|
0.45
|
| Total Non Current Assets |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Total Liabilities Net Minority Interest |
|
2.87
-93.09%
|
41.59
-10.11%
|
46.27
+5.68%
|
43.78
|
| Current Liabilities |
|
2.87
-55.70%
|
6.49
+106.69%
|
3.14
+20.31%
|
2.61
|
| Payables And Accrued Expenses |
|
1.66
+20.30%
|
1.38
+58.14%
|
0.87
+39.30%
|
0.63
|
| Payables |
|
0.27
+5.56%
|
0.25
-28.81%
|
0.35
+70.19%
|
0.21
|
| Accounts Payable |
|
0.27
+5.56%
|
0.25
-28.61%
|
0.35
+71.36%
|
0.21
|
| Other Payable |
|
—
|
—
|
0.00
-50.00%
|
0.00
|
| Current Accrued Expenses |
|
1.39
+23.60%
|
1.13
+117.57%
|
0.52
+23.92%
|
0.42
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.02
+350.00%
|
0.00
+33.33%
|
0.00
+50.00%
|
0.00
|
| Current Debt And Capital Lease Obligation |
|
1.20
-75.79%
|
4.95
+2254.76%
|
0.21
|
—
|
| Current Debt |
|
1.20
-75.79%
|
4.95
+2254.76%
|
0.21
|
—
|
| Other Current Borrowings |
|
1.20
-75.79%
|
4.95
+2254.76%
|
0.21
|
—
|
| Current Deferred Liabilities |
|
—
|
0.00
-100.00%
|
2.05
+3.69%
|
1.98
|
| Current Deferred Revenue |
|
—
|
0.00
-100.00%
|
2.05
+3.69%
|
1.98
|
| Other Current Liabilities |
|
—
|
0.16
|
—
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
0.00
-100.00%
|
35.10
-18.62%
|
43.13
+4.75%
|
41.17
|
| Long Term Debt And Capital Lease Obligation |
|
—
|
—
|
7.41
+14.42%
|
6.47
|
| Long Term Debt |
|
—
|
—
|
7.41
+14.42%
|
6.47
|
| Preferred Securities Outside Stock Equity |
|
0.00
-100.00%
|
35.10
+0.00%
|
35.10
+3.19%
|
34.01
|
| Stockholders Equity |
|
4.74
+111.54%
|
-41.10
+10.46%
|
-45.91
-9.14%
|
-42.06
|
| Common Stock Equity |
|
4.74
+111.54%
|
-41.10
+10.46%
|
-45.91
-9.14%
|
-42.06
|
| Capital Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Common Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
5.18
+0.00%
|
5.18
+5.07%
|
4.93
+0.00%
|
4.93
|
| Ordinary Shares Number |
|
5.18
+0.00%
|
5.18
+5.07%
|
4.93
+0.00%
|
4.93
|
| Additional Paid In Capital |
|
60.54
+5709.79%
|
1.04
+0.00%
|
1.04
+38.20%
|
0.75
|
| Retained Earnings |
|
-55.79
-32.38%
|
-42.15
+10.23%
|
-46.95
-9.65%
|
-42.81
|
| Total Equity Gross Minority Interest |
|
4.74
+111.54%
|
-41.10
+10.46%
|
-45.91
-9.14%
|
-42.06
|
| Total Capitalization |
|
4.74
+111.54%
|
-41.10
-6.76%
|
-38.50
-8.18%
|
-35.59
|
| Working Capital |
|
4.74
+178.99%
|
-6.01
-116.12%
|
-2.78
-211.55%
|
-0.89
|
| Invested Capital |
|
5.94
+116.43%
|
-36.16
+5.57%
|
-38.29
-7.59%
|
-35.59
|
| Total Debt |
|
1.20
-75.79%
|
4.95
-35.06%
|
7.62
+17.66%
|
6.47
|
| Net Debt |
|
—
|
4.72
-35.13%
|
7.27
+38.95%
|
5.23
|
| Net Tangible Assets |
|
4.74
+111.54%
|
-41.10
+10.46%
|
-45.91
-9.14%
|
-42.06
|
| Tangible Book Value |
|
4.74
+111.54%
|
-41.10
+10.46%
|
-45.91
-9.14%
|
-42.06
|
| Derivative Product Liabilities |
|
—
|
0.00
-100.00%
|
0.62
-9.05%
|
0.69
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-1.38
-114.51%
|
-0.64
+47.46%
|
-1.22
+18.88%
|
-1.50
|
| Cash Flow From Continuing Operating Activities |
|
-1.38
-114.51%
|
-0.64
+47.46%
|
-1.22
+18.88%
|
-1.50
|
| Net Income From Continuing Operations |
|
-13.65
-384.27%
|
4.80
+216.19%
|
-4.13
-185.16%
|
-1.45
|
| Other Non Cash Items |
|
5.26
+258.82%
|
-3.31
-251.09%
|
2.19
+452.14%
|
0.40
|
| Operating Gains Losses |
|
6.88
+1396.05%
|
-0.53
-4927.27%
|
0.01
+103.34%
|
-0.33
|
| Gain Loss On Investment Securities |
|
-0.16
+65.44%
|
-0.46
-646.77%
|
-0.06
+38.00%
|
-0.10
|
| Net Foreign Currency Exchange Gain Loss |
|
0.00
+100.00%
|
-0.07
-193.15%
|
0.07
+131.88%
|
-0.23
|
| Change In Working Capital |
|
0.13
+108.19%
|
-1.60
-325.53%
|
0.71
+676.42%
|
-0.12
|
| Change In Payables And Accrued Expense |
|
0.29
+121.60%
|
-1.36
-651.01%
|
0.25
+1552.94%
|
-0.02
|
| Change In Payable |
|
0.29
+121.60%
|
-1.36
-651.01%
|
0.25
+1552.94%
|
-0.02
|
| Change In Account Payable |
|
0.01
+113.86%
|
-0.10
-168.71%
|
0.15
+244.12%
|
-0.10
|
| Change In Other Current Assets |
|
-0.16
+31.51%
|
-0.24
-151.52%
|
0.46
+535.85%
|
-0.11
|
| Financing Cash Flow |
|
8.52
+1523.62%
|
0.53
+61.54%
|
0.33
|
0.00
|
| Cash Flow From Continuing Financing Activities |
|
8.52
+1523.62%
|
0.53
+61.54%
|
0.33
|
0.00
|
| Net Issuance Payments Of Debt |
|
0.30
-42.86%
|
0.53
+61.54%
|
0.33
|
0.00
|
| Issuance Of Debt |
|
0.30
-64.71%
|
0.85
+161.54%
|
0.33
|
0.00
|
| Repayment Of Debt |
|
0.00
+100.00%
|
-0.33
|
0.00
|
—
|
| Long Term Debt Issuance |
|
0.00
-100.00%
|
0.45
|
0.00
|
0.00
|
| Net Long Term Debt Issuance |
|
0.00
-100.00%
|
0.45
|
0.00
|
0.00
|
| Short Term Debt Issuance |
|
0.30
-25.00%
|
0.40
+23.08%
|
0.33
|
0.00
|
| Short Term Debt Payments |
|
0.00
+100.00%
|
-0.33
|
0.00
|
—
|
| Net Short Term Debt Issuance |
|
0.30
+300.00%
|
0.07
-76.92%
|
0.33
|
0.00
|
| Net Common Stock Issuance |
|
8.22
|
0.00
|
0.00
|
—
|
| Changes In Cash |
|
7.15
+6262.93%
|
-0.12
+87.04%
|
-0.90
+40.49%
|
-1.50
|
| Beginning Cash Position |
|
0.23
-33.62%
|
0.34
-72.18%
|
1.24
-54.81%
|
2.74
|
| End Cash Position |
|
7.38
+3121.83%
|
0.23
-33.62%
|
0.34
-72.18%
|
1.24
|
| Free Cash Flow |
|
-1.38
-114.51%
|
-0.64
+47.46%
|
-1.22
+18.88%
|
-1.50
|
| Common Stock Issuance |
|
8.22
|
0.00
|
0.00
|
—
|
| Earnings Losses From Equity Investments |
|
7.04
|
0.00
|
—
|
—
|
| Issuance Of Capital Stock |
|
8.22
|
0.00
|
0.00
|
—
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|